Peldesine

培得星

Report date: 2022/07/18 15:43:40
NME

Base Information

Drug NamePeldesine
Drug Alias NameBCX-34BCX-34-B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurine nucleoside phosphorylase inhibitorsImmunosuppressants
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiocryst Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksKEGG